25-Hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?

Rheumatology International

Volumn 32, Issue 12, 2012, Pages 3923-3929

  Pelajo, Christina F ^a   Lopez Benitez, Jorge M ^a,b   Kent, David M ^c   Price, Lori Lyn ^c   Miller, Laurie C ^a,b   Dawson Hughes, Bess ^b,d  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

25 Hydroxyvitamin D; Arthritis; Inflammation; Juvenile; Rheumatoid

Indexed keywords

25 HYDROXYVITAMIN D;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CAUCASIAN; CHILD; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL VARIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84872237166     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2287-y     Document Type: Article

References (44)

1. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann Rheum Dis 66(9):1137-1142. doi:10.1136/ard.2007.069831
2. Cantorna MT, Yu S, Bruce D (2008) The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med 29(6):369-375. doi:10.1016/j.mam. 2008.04.004
3. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE (2007) Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179(3):1634-1647. doi:179/3/1634
4. Jirapongsananuruk O, Melamed I, Leung DY (2000) Additive immunosuppressive effects of 1, 25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol 106(5):981-985. doi:10.1067/mai.2000.110101
5. Lemire J (2000) 1, 25-Dihydroxyvitamin D3-a hormone with immunomodulatory properties. Z Rheumatol 59(Suppl 1):24-27
6. Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1, 25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 125(6 Suppl):1704S-1708S
7. van Etten E, Mathieu C (2005) Immunoregulation by 1, 25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol 97(1-2):93-101. doi:10.1016/j.jsbmb.2005.06.002
8. van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO (2004) 1 alpha, 25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 23(3):233-239. doi:10.1016/j.jaut.2004.06.004
9. Pelajo CF, Lopez-Benitez JM, Miller LC (2010) Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 9(7):507-510. doi:10.1016/j.autrev.2010. 02.011
10. Cutolo M, Otsa K, Paolino S, Yprus M, Veldi T, Seriolo B (2009) Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis 68(3):446-447. doi: 10.1136/ard.2008.093476
11. Kamen D, Aranow C (2008) Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 20(5):532-537. doi: 10.1097/BOR.0b013e32830a991b
12. Carvalho JF (2007) Anti-vitamin D, vitamin D in SLE. Ann N Y Acad Sci 1109:550-557
13. Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K (1995) Vitamin D3 metabolism in patients with rheumatic diseases: Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14(4):397-400
14. Ruiz-Irastorza G, Egurbide MV, Olivares N,Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6):920-923. doi:10.1093/rheumatology/ken121
15. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5(2):114-117. doi:10.1016/ j.autrev.2005.05.009
16. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M (2009) Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 20(3):427-433. doi:10.1007/s00198-008-0676-1
17. Becker A, Fischer R, Schneider M (2001) Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol 60(5):352-358
18. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B (2007) Vitamin D in rheumatoid arthritis. Autoimmun Rev 7(1):59-64. doi: 10.1016/j.autrev.2007.07. 001
19. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study. Arthritis Rheum 50(1):72-77. doi:10.1002/art.11434
20. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E (2008) Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 67(4):530-535. doi:10.1136/ard.2007.072736
21. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56(7):2143-2149. doi:10.1002/art.22722
22. Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B (2006) Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24(6):702-704. doi:1964
23. Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G, Stein G (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62(3):193-198
24. Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16(12):1999-2004. doi:10.1007/s00198- 005-1990-5
25. Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369(9563):767-778. doi:10.1016/S0140-6736(07)60363-8
26. Pelajo CF, Lopez-Benitez JM, Miller LC (2011) 25-Hydroxyvitamin D Levels and vitamin D deficiency in children with rheumatologic disorders and controls. J Rheumatol 38:2000-2004. doi:10.3899/jrheum.110123
27. Bianchi ML, Bardare M, Caraceni MP, Cohen E, Falvella S, Borzani M, DeGaspari MG (1990) Bone metabolism in juvenile rheumatoid arthritis. Bone Miner 9(2):153-162
28. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658-666. doi:10.1002/art.24516
29. Cannell JJ, Hollis BW, Zasloff M, Heaney RP (2008) Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 9(1):107-118. doi:10.1517/14656566.9.1.107
30. Mark S, Gray-Donald K, Delvin EE, O'Loughlin J, Paradis G, Levy E, Lambert M (2008) Low vitamin D status in a representative sample of youth from Quebec, Canada. Clin Chem 54(8):1283-1289. doi:10.1373/clinchem.2008.104158
31. Zittermann A (2003) Vitamin D in preventive medicine: Are we ignoring the evidence? Br J Nutr 89(5):552-572. doi:10.1079/ BJN2003837
32. Update (1997) Prevalence of overweight among children, adolescents, and adults-United States, 1988-1994. MMWR Morb Mortal Wkly Rep 46(9):198-202
33. Harris SS, Dawson-Hughes B (1998) The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J Am Coll Nutr 17(3):282-284
34. Heaney RP (2005) The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97(1-2):13-19. doi:10.1016/ j.jsbmb.2005.06.020
35. Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S-1688S. doi:80/6/1678S
36. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266-281. doi:10.1056/NEJMra070553
37. Mansbach JM, Ginde AA, Camargo CA Jr (2009) Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: Do children need more vitamin D? Pediatrics 124(5):1404-1410. doi:10.1542/peds.2008-2041
38. Greer FR (2009) Defining vitamin D deficiency in children: Beyond 25-OH vitamin D serum concentrations. Pediatrics 124(5):1471-1473. doi:10.1542/peds.2009-2307
39. Tsai CL, Camargo CA Jr (2009) Methodological considerations, such as directed acyclic graphs, for studying "acute on chronic" disease epidemiology: Chronic obstructive pulmonary disease example. J Clin Epidemiol 62(9):982-990. doi:10.1016/j.jclinepi. 2008.10.005
40. Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R (2008) Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93(9):3430-3435. doi:10.1210/ jc.2008-0241
41. Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, Silverman ED (2007) Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: Ethnicity as a risk factor. Arthritis Rheum 56(6):1974-1984. doi:10.1002/art.22709
42. Schwartz MM, Simpson P, Kerr KL, Jarvis JN (1997) Juvenile rheumatoid arthritis in African Americans. J Rheumatol 24(9): 1826-1829
43. Holick MF (2003) Vitamin D: A millenium perspective. J Cell Biochem 88(2):296-307. doi:10.1002/jcb.10338
44. Dong Y, Pollock N, Stallmann-Jorgensen IS, Gutin B, Lan L, Chen TC, Keeton D, Petty K, Holick MF, Zhu H (2010) Low 25-hydroxyvitamin D levels in adolescents: Race, season, adiposity, physical activity, and fitness. Pediatrics 125(6):1104-1111. doi:10.1542/peds.2009-2055